Produktinformation
Teglarinadchloride is a molecule that has been shown to have significant cytotoxicity against cancer cells. It is an inhibitor of the pyrimidine metabolism, which leads to the accumulation of uracil in DNA and disrupts DNA synthesis. Teglarinadchloride also inhibits the activity of the enzyme ribonucleotide reductase, which is vital for cell growth and proliferation. This drug has been clinically studied as a potential treatment for bowel disease, autoimmune diseases, and cancer. Teglarinadchloride also displays potent antitumor activity by targeting solid tumours through its potent antiproliferative effects on cancer cells and its ability to inhibit angiogenesis.